Trials / Unknown
UnknownNCT00874146
Level of HER2-neu Gene Amplification an Response to Trastuzumab
Retrospective Study of the Level of HER2-neu Gene Amplification as Predictive Factor of Response in Patients With HER2-positive Advanced Breast Cancer Treated With Trastuzumab Containing Regimens.
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Istituto Clinico Humanitas · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Primary objective of the study is to evaluate the correlation between level of HER2-neu gene amplification evalued by dual-color Fluorescent in-situ hybridization (FISH) test and time to progression (TTP) in patients with HER2-positive advanced breast cancer treated with trastuzumab-containing regimens.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | Fluorescent in-situ hybridization (FISH) | Dual color FISH test to assess ratio of HER2/neu amplification |
Timeline
- Start date
- 2009-03-01
- Primary completion
- 2009-09-01
- Completion
- 2009-12-01
- First posted
- 2009-04-02
- Last updated
- 2010-09-02
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT00874146. Inclusion in this directory is not an endorsement.